The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets1
Peter J. Malloy,
J. Wesley Pike and
David Feldman
Department of Medicine (P.J.M., D.F.), Stanford University School
of Medicine, Stanford, California 94305-5103; and Department of
Molecular and Cellular Physiology (J.W.P.), University of
Cincinnati, Cincinnati, Ohio 45267
I. The Syndrome of Hereditary 1,25-Dihydroxyvitamin D-ResistantRickets
(HVDRR)
A. Historical
B. Clinical features of HVDRR
C. Pathophysiology
D. Alopecia
E. 1,25-DihydroxyvitaminD [1,25-(OH)2D] action and HVDRR
II. Vitamin D Physiology
A. Metabolism
B. 1-Hydroxylase deficiency
III. 1,25-DihydroxyvitaminD Action Mediated by the VitaminD receptor (VDR)
A. Historicalaspects of VDR structure and function
B. The domain structureof the VDR
C. The regulation of gene expression by the VDR
IV. Cellular Basis of HVDRR
A. Studies in cultured skinfibroblasts
B. Studies in other cells
V. The VDR Gene andthe Molecular Basis of HVDRR
A. The VDR chromosomal gene
B.The VDR gene promoter
C. Polymorphisms of the VDR gene
VI.HVDRR Mutations Causing the Ligand-Binding Positive Phenotype
A. Initial description of DNA-binding domain (DBD) mutations
B. Characterization of additional DBD mutations
C. Structuralanalysis of DBD mutations
VII. HVDRR Mutations Causing theLigand-Binding Negative Phenotype
A. Initial description ofligand-binding domain (LBD) mutations
B. Characterizationof additional LBD mutations
C. Structural analysis of LBDmutations
VIII. Additional Mutations In The VDR Gene
A.Hinge region mutations
B. Splice site mutations
C. Majorstructural mutations
D. Vitamin D resistance without a mutationin the VDR
IX. HVDRR Mouse Model
X. Treatment of HVDRR
A.Vitamin D
B. Calcium
C. Prenatal diagnosis
D. Spontaneoushealing of rickets
XI. Analysis, Summary, and Conclusions
This article has been cited by other articles:
P. J. Malloy, J. Wang, K. Jensen, and D. Feldman Modulation of Vitamin D Receptor Activity by the Corepressor Hairless: Differential Effects of Hairless Isoforms
Endocrinology,
November 1, 2009;
150(11):
4950 - 4957.
[Abstract][Full Text][PDF]
J. W. Pike, M. B. Meyer, and M. L. Martowicz New Techniques in Transcription Research Extend Our Understanding of the Molecular Actions of the Vitamin D Hormone
IBMS BoneKEy,
May 1, 2009;
6(5):
169 - 180.
[Abstract][Full Text][PDF]
P. J. Malloy, L. Peng, J. Wang, and D. Feldman Interaction of the Vitamin D Receptor with a Vitamin D Response Element in the Mullerian-Inhibiting Substance (MIS) Promoter: Regulation of MIS Expression by Calcitriol in Prostate Cancer Cells
Endocrinology,
April 1, 2009;
150(4):
1580 - 1587.
[Abstract][Full Text][PDF]
D.-Y. Tseng, M.-Y. Chou, Y.-C. Tseng, C.-D. Hsiao, C.-J. Huang, T. Kaneko, and P.-P. Hwang Effects of stanniocalcin 1 on calcium uptake in zebrafish (Danio rerio) embryo
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2009;
296(3):
R549 - R557.
[Abstract][Full Text][PDF]
D. Bikle Nonclassic Actions of Vitamin D
J. Clin. Endocrinol. Metab.,
January 1, 2009;
94(1):
26 - 34.
[Abstract][Full Text][PDF]
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Endocr. Rev.,
October 1, 2008;
29(6):
726 - 776.
[Abstract][Full Text][PDF]
A. L. M. Sutton, X. Zhang, D. R. Dowd, Y. P. Kharode, B. S. Komm, and P. N. MacDonald Semaphorin 3B Is a 1,25-Dihydroxyvitamin D3-Induced Gene in Osteoblasts that Promotes Osteoclastogenesis and Induces Osteopenia in Mice
Mol. Endocrinol.,
June 1, 2008;
22(6):
1370 - 1381.
[Abstract][Full Text][PDF]
D. Praslickova, S. Sharif, A. Sarson, M. F. Abdul-Careem, D. Zadworny, A. Kulenkamp, G. Ansah, and U. Kuhnlein Association of a Marker in the Vitamin D Receptor Gene with Marek's Disease Resistance in Poultry
Poult. Sci.,
June 1, 2008;
87(6):
1112 - 1119.
[Abstract][Full Text][PDF]
J. Wang, P. J. Malloy, and D. Feldman Interactions of the Vitamin D Receptor with the Corepressor Hairless: ANALYSIS OF HAIRLESS MUTANTS IN ATRICHIA WITH PAPULAR LESIONS
J. Biol. Chem.,
August 31, 2007;
282(35):
25231 - 25239.
[Abstract][Full Text][PDF]
L. Cianferotti, M. Cox, K. Skorija, and M. B. Demay Vitamin D receptor is essential for normal keratinocyte stem cell function
PNAS,
May 29, 2007;
104(22):
9428 - 9433.
[Abstract][Full Text][PDF]
D. D. Moore, S. Kato, W. Xie, D. J. Mangelsdorf, D. R. Schmidt, R. Xiao, and S. A. Kliewer International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor
Pharmacol. Rev.,
December 1, 2006;
58(4):
742 - 759.
[Abstract][Full Text][PDF]
M. B. Meyer, M. Watanuki, S. Kim, N. K. Shevde, and J. W. Pike The Human Transient Receptor Potential Vanilloid Type 6 Distal Promoter Contains Multiple Vitamin D Receptor Binding Sites that Mediate Activation by 1,25-Dihydroxyvitamin D3 in Intestinal Cells
Mol. Endocrinol.,
June 1, 2006;
20(6):
1447 - 1461.
[Abstract][Full Text][PDF]
Z. Xie, S. Chang, Y. Oda, and D. D. Bikle Hairless Suppresses Vitamin D Receptor Transactivation in Human Keratinocytes
Endocrinology,
January 1, 2006;
147(1):
314 - 323.
[Abstract][Full Text][PDF]
K. Skorija, M. Cox, J. M. Sisk, D. R. Dowd, P. N. MacDonald, C. C. Thompson, and M. B. Demay Ligand-Independent Actions of the Vitamin D Receptor Maintain Hair Follicle Homeostasis
Mol. Endocrinol.,
April 1, 2005;
19(4):
855 - 862.
[Abstract][Full Text][PDF]
L. Schneider, C. El-Yazidi, A. Dace, M. Maraninchi, R. Planells, A. Margotat, and J. Torresani Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway
J. Mol. Endocrinol.,
February 1, 2005;
34(1):
221 - 235.
[Abstract][Full Text][PDF]
P. J. Malloy, R. Xu, L. Peng, S. Peleg, A. Al-Ashwal, and D. Feldman Hereditary 1,25-Dihydroxyvitamin D Resistant Rickets due to a Mutation Causing Multiple Defects in Vitamin D Receptor Function
Endocrinology,
November 1, 2004;
145(11):
5106 - 5114.
[Abstract][Full Text][PDF]
J. M. Zarach, G. M. J. Beaudoin III, P. A. Coulombe, and C. C. Thompson The co-repressor hairless has a role in epithelial cell differentiation in the skin
Development,
September 1, 2004;
131(17):
4189 - 4200.
[Abstract][Full Text][PDF]
B.A. Rybicki, M.J. Maliarik, L.M. Poisson, and M.C. Iannuzzi Sarcoidosis and granuloma genes: a family-based study in African-Americans
Eur. Respir. J.,
August 1, 2004;
24(2):
251 - 257.
[Abstract][Full Text][PDF]
I. Oakley-Girvan, D. Feldman, T. R. Eccleshall, R. P. Gallagher, A. H. Wu, L. N. Kolonel, J. Halpern, R. R. Balise, D. W. West, R. S. Paffenbarger Jr., et al. Risk of Early-Onset Prostate Cancer in Relation to Germ Line Polymorphisms of the Vitamin D Receptor
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2004;
13(8):
1325 - 1330.
[Abstract][Full Text][PDF]
T.-M. Nguyen, M. Lieberherr, J. Fritsch, H. Guillozo, M. L. Alvarez, Z. Fitouri, F. Jehan, and M. Garabedian The Rapid Effects of 1,25-Dihydroxyvitamin D3 Require the Vitamin D Receptor and Influence 24-Hydroxylase Activity: STUDIES IN HUMAN SKIN FIBROBLASTS BEARING VITAMIN D RECEPTOR MUTATIONS
J. Biol. Chem.,
February 27, 2004;
279(9):
7591 - 7597.
[Abstract][Full Text][PDF]
B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate
Endocr. Rev.,
December 1, 2003;
24(6):
782 - 801.
[Abstract][Full Text][PDF]
J.-C. Hsieh, J. M. Sisk, P. W. Jurutka, C. A. Haussler, S. A. Slater, M. R. Haussler, and C. C. Thompson Physical and Functional Interaction between the Vitamin D Receptor and Hairless Corepressor, Two Proteins Required for Hair Cycling
J. Biol. Chem.,
October 3, 2003;
278(40):
38665 - 38674.
[Abstract][Full Text][PDF]
J. Welsh, J. A. Wietzke, G. M. Zinser, B. Byrne, K. Smith, and C. J. Narvaez Vitamin D-3 Receptor as a Target for Breast Cancer Prevention
J. Nutr.,
July 1, 2003;
133(7):
2425S - 2433.
[Abstract][Full Text][PDF]
D. M. Peehl, A. V. Krishnan, and D. Feldman Pathways Mediating the Growth-Inhibitory Actions of Vitamin D in Prostate Cancer
J. Nutr.,
July 1, 2003;
133(7):
2461S - 2469.
[Abstract][Full Text][PDF]
H. Chen, M. Hewison, B. Hu, and J. S. Adams Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance
PNAS,
May 13, 2003;
100(10):
6109 - 6114.
[Abstract][Full Text][PDF]
A. L. M. Sutton and P. N. MacDonald Vitamin D: More Than a "Bone-a-Fide" Hormone
Mol. Endocrinol.,
May 1, 2003;
17(5):
777 - 791.
[Abstract][Full Text][PDF]
Y. Xu, A. Shibata, J. E. McNeal, T. A. Stamey, D. Feldman, and D. M. Peehl Vitamin D Receptor Start Codon Polymorphism (FokI) and Prostate Cancer Progression
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2003;
12(1):
23 - 27.
[Abstract][Full Text][PDF]
P. J. Malloy, R. Xu, L. Peng, P. A. Clark, and D. Feldman A Novel Mutation in Helix 12 of the Vitamin D Receptor Impairs Coactivator Interaction and Causes Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets without Alopecia
Mol. Endocrinol.,
November 1, 2002;
16(11):
2538 - 2546.
[Abstract][Full Text][PDF]
R. G. Erben, D. W. Soegiarto, K. Weber, U. Zeitz, M. Lieberherr, R. Gniadecki, G. Moller, J. Adamski, and R. Balling Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D
Mol. Endocrinol.,
July 1, 2002;
16(7):
1524 - 1537.
[Abstract][Full Text][PDF]
S. Ando, N. J. Sarlis, J. Krishnan, X. Feng, S. Refetoff, M. Q. Zhang, E. H. Oldfield, and P. M. Yen Aberrant Alternative Splicing of Thyroid Hormone Receptor in a TSH-Secreting Pituitary Tumor Is A Mechanism for Hormone Resistance
Mol. Endocrinol.,
September 1, 2001;
15(9):
1529 - 1538.
[Abstract][Full Text][PDF]
K. L. Sunn, T.-A. Cock, L. A. Crofts, J. A. Eisman, and E. M. Gardiner Novel N-Terminal Variant of Human VDR
Mol. Endocrinol.,
September 1, 2001;
15(9):
1599 - 1609.
[Abstract][Full Text][PDF]
Y. C. Li, M. J. G. Bolt, L.-P. Cao, and M. D. Sitrin Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism
Am J Physiol Endocrinol Metab,
September 1, 2001;
281(3):
E558 - E564.
[Abstract][Full Text][PDF]
M Li, H Chiba, X Warot, N Messaddeq, C Gerard, P Chambon, and D Metzger RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations
Development,
January 3, 2001;
128(5):
675 - 688.
[Abstract][PDF]
S. J. Marx Hyperparathyroid and Hypoparathyroid Disorders
N. Engl. J. Med.,
December 21, 2000;
343(25):
1863 - 1875.
[Full Text][PDF]
Y.-Y. Liu, C. Nguyen, and S. Peleg Regulation of Ligand-Induced Heterodimerization and Coactivator Interaction by the Activation Function-2 Domain of the Vitamin D Receptor
Mol. Endocrinol.,
November 1, 2000;
14(11):
1776 - 1787.
[Abstract][Full Text]
A. Slominski and J. Wortsman Neuroendocrinology of the Skin
Endocr. Rev.,
October 1, 2000;
21(5):
457 - 487.
[Abstract][Full Text]
S. Swami, A. V. Krishnan, and D. Feldman 1{{alpha}},25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells
Clin. Cancer Res.,
August 1, 2000;
6(8):
3371 - 3379.
[Abstract][Full Text]
Y. Sakai and M. B. Demay Evaluation of Keratinocyte Proliferation and Differentiation in Vitamin D Receptor Knockout Mice
Endocrinology,
June 1, 2000;
141(6):
2043 - 2049.
[Abstract][Full Text][PDF]
S. A. Gardezi, C. Nguyen, P. J. Malloy, G. H. Posner, D. Feldman, and S. Peleg A Rationale for Treatment of Hereditary Vitamin D-resistant Rickets with Analogs of 1alpha ,25-Dihydroxyvitamin D3
J. Biol. Chem.,
July 27, 2001;
276(31):
29148 - 29156.
[Abstract][Full Text][PDF]